1244
S. Rostamizadeh et al.
N-Methyl-4-phenyl-2-thiazolamine (3e, C10H10N2S)
White crystals, 0.155g (82%), mp 134–136ꢁC; IR (KBr): ꢂꢀ¼
N-Phenyl-4-nitrophenyl-2-thiazolamine (3j, C15H11N3O2S)
Light orange crystalline powder, 0.295g (quantitative), mp
1
3219, 3106, 3003, 2916, 1586, 1456, 1376cmꢂ1; H NMR
226–229ꢁC; IR (KBr): ꢂꢀ¼ 3288, 3145, 3102, 1622cmꢂ1
;
(300 MHz, DMSO-d6): ꢁ ¼ 2.88 (d, J ¼ 4.8 Hz, 3H), 7.02 (s,
1H), 7.25 (t, J ¼ 4.2 Hz, 1H), 7.36 (t, J ¼ 7.5 Hz, 2H), 7.55 (q,
J ¼ 4.8 Hz, 1H), 7.85 (d, J ¼ 4.2, 2H) ppm; 13C NMR (75 MHz,
DMSO-d6): ꢁ ¼ 31.0 (NHCH3), 100.7, 125.6, 127.2, 128.4,
134.9, 150.2, 169.3 (N–C–S fragment in thiazole ring) ppm;
MS (EI, 70eV): m=z (%) ¼ 190 (100) [Mþ], 162 (33), 134 (40),
102 (20), 45 (10).
1H NMR (300MHz, DMSO-d6): ꢁ ¼ 6.98 (t, J ¼ 6.0 Hz, 1H),
7.35 (t, J ¼ 7.5 Hz), 7.72 (d, J ¼ 7.5 Hz, 3H), 8.16 (d, J ¼
4.5 Hz, 2H), 8.27 (d, J ¼ 4.5Hz, 2H); 13C NMR (75 MHz,
DMSO-d6): ꢁ ¼ 108.0, 117.0, 121.5, 124.2, 126.5, 129.1,
140.5, 141.0, 146.2, 148.1, 163.5 ppm; MS (EI, 70eV): m=z
(%) ¼ 297 (100) [Mþ], 267 (30), 251 (80), 150 (75), 104 (30).
N-Phenyl-4-methoxyphenyl-2-thiazolamine
(3k, C16H14N2OS)
N-Methyl-4-bromophenyl-2-thiazolamine
(3f, C10H9BrN2S)
White crystalline powder, 0.268g (95%), mp 182–184ꢁC; IR
White crystals, 0.229g (85%), mp 146–148ꢁC; IR (KBr): ꢂꢀ¼
(KBr): ꢂꢀ¼ 3291, 3159, 3098, 2951, 1617cmꢂ1
;
1H NMR
1
3250, 3111, 3008, 2931, 1576, 1486, 1396cmꢂ1; H NMR
(300MHz, DMSO-d6): ꢁ ¼ 3.77 (s, 3H, OCH3), 6.97 (t, J ¼
8.4 Hz, 3H), 7.14 (s, 1H), 7.34 (t, J ¼ 8.4Hz, 2H), 7.71
(d, J ¼ 8.4 Hz, 2H), 7.83 (d, J ¼ 8.4Hz, 2H), 10.35 (s, 1H,
NH) ppm; 13C NMR (75 MHz, DMSO-d6): ꢁ ¼ 55.2, 100.8,
114.1, 117.1, 121.5, 127.1, 127.1, 129.2, 141.1, 149.4, 159.0,
163.4 ppm; MS (EI, 70eV): m=z (%) ¼ 282 (100) [Mþ], 150
(15), 93 (10), 64 (15).
(300 MHz, DMSO-d6): ꢁ ¼ 2.86 (d, J ¼ 4.8 Hz, 3H), 7.12 (s,
1H), 7.52 (t, J ¼ 2.1 Hz, 1H), 7.55 (t, J ¼ 1.8 Hz, 1H), 7.58 (q,
J ¼ 5.1 Hz, 1H), 7.76 (t, J ¼ 5.1, 1H), 7.79 (t, J ¼ 5.1 Hz, 1H)
ppm; 13C NMR (75 MHz, DMSO-d6): ꢁ ¼ 30.9 (NHCH3),
101.7, 120.1, 127.6, 131.3 (C–Br phenyl ring), 134.1, 148.9
(C–N thiazole ring), 169.4 (N–C–S fragment in thiazole ring)
ppm; MS (EI, 70 eV): m=z (%) ¼ 270 (100) [Mþ], 272 (98)
[Mþ þ 2], 240 (40), 214 (15), 182 (20), 133 (30), 89 (50),
45 (10).
Acknowledgements
We are grateful to the Research Council of K.N. Toosi
University of Technology for partial financial support and
Dr. K. Jadidi from Shahid Beheshti University for helpful
discussions.
N-Methyl-4-methoxyphenyl-2-thiazolamine
(3g, C11H12N2OS)
White crystals, 0.204 g (93%), mp 126–128ꢁC; IR (KBr):
ꢂꢀ¼ 3266, 3101, 3004, 2921, 1581, 1477, 1380 cmꢂ1
;
1H
NMR (300 MHz, DMSO-d6): ꢁ ¼ 2.85 (d, J ¼ 4.8Hz, 3H),
3.76 (s, 3H), 6.85 (s, 1H), 6.91 (d, J ¼ 8.7 Hz, 2H), 7.49 (q,
J ¼ 4.8 Hz, 1H), 7.75 (d, J ¼ 8.7 Hz, 2H) ppm; 13C NMR
(75 MHz, DMSO-d6): ꢁ ¼ 31.0 (NHCH3), 55.0 (OMe), 98.6,
113.8, 126.9, 127.8, 150.0 (C–OMe in phenyl ring), 158.6 (C–
N thiazole ring), 169.3 (N–C–S fragment in thiazole ring)
ppm; MS (EI, 70 eV): m=z (%) ¼ 220 (100) [Mþ], 192 (25),
149 (50), 121 (30), 77 (20), 45(20).
References
1. Lewis JR (1996) Nat Prod Rep 13:435
2. Hargrave KD, Hess FK, Oliver JT (1983) J Med Chem
26:1158
3. Patt WC, Hamilton HW, Taylor MD, Ryan MJ, Taylor
DG Jr, Connolly CJC, Doherty AM, Klutchko SR, Sircar
I, Steinbaugh BA, Batley BL, Painchaud CA, Rapundalo
ST, Michniewicz BM, Olson SCJ (1992) J Med Chem
35:2562
4. Haviv F, Ratajczyk JD, DeNet RW, Kerdesky FA, Walters
RL, Schmidt SP, Holms JH, Young PR, Carter GW (1988)
J Med Chem 31:1719
5. Davies JH Jr, Forrester KJ (1999) Tetrahedron Lett
40:1621
6. Dondoni A, Merino P (1996) Thiazoles. In: Katritzky AR,
Rees CW, Scriven EFV (eds) Comprehensive Heterocy-
clic Chemistry, vol 3, Pergamon Press, Elsevier Science
Ltd., p 432
7. Kazzouli SE, Berteina-Raboin S, Mouaddib A, Guillaumet
G (2002) Tetrahedron Lett 43:3193
N-Methyl-4-nitrophenyl-2-thiazolamine (3h, C10H9N3O2S)
Light orange crystalline powder, 0.234 g (90), mp 214–217ꢁC;
IR (KBr): ꢂꢀ¼ 3255, 3111, 3003, 2916, 1601, 1498, 1378,
1335 cmꢂ1
;
1H NMR (300 MHz, DMSO-d6): ꢁ ¼ 2.89 (d,
J ¼ 4.5 Hz, 3H), 7.43 (s, 1H), 7.71 (d, J ¼ 4.5 Hz, 1H), 8.06
(dt, J ¼ 8.7 Hz, J ¼ 2.1, 2H), 8.22 (dt, J ¼ 8.7 Hz, J ¼ 2.1, 2H)
ppm; 13C NMR (75 MHz, DMSO-d6): ꢁ ¼ 30.9 (NHCH3),
105.9, 123.9, 126.3, 140.8 (C–NO2), 146.0, 148.1, 169.5
(N–C–S fragment in thiazole ring) ppm; MS (EI, 70eV):
m=z (%) ¼ 235 (100) [Mþ], 207 (70), 174 (35), 121 (20), 89
(50), 30 (25).
N-Phenyl-4-phenyl-2-thiazolamine (3i, C15H12N2S)
White crystalline powder, 0.225 g (90%), mp 142ꢁC (Ref. [23]
134–136ꢁC); IR (KBr): ꢂꢀ¼ 3250, 3121, 3060, 2916,
8. Karade H, Sathe M, Kaushik MP (2007) Catalysis Com-
mun 8:741
9. Narender M, Saidi Reddy V, Sridhar R, Nageswar YVD,
Rama Rao K (2005) Tetrahedron Lett 46:5953
10. Das B, Saidi Reddy V, Ramu R (2006) J Mol Cat A
252:235
1607 cmꢂ1
;
1H NMR (300 MHz, DMSO-d6): ꢁ ¼ 6.97 (t,
J ¼ 7.5 Hz, 1H), 7.28–7.44 (m, 6H), 7.72 (d, J ¼ 8.1 Hz,
2H), 7.90 (d, J ¼ 7.2Hz, 2H), 10.38 (s, 1H) ppm; 13C NMR
(75 MHz, DMSO-d6): ꢁ ¼ 103.0, 117.2, 121.6, 125.8, 127.8,
128.8, 129.2, 134.3, 141.1, 149.6, 163.4ppm.
11. Kabalka GW, Mereddy AR (2006) Tetrahedron Lett
47:5171